Global pharma major Lupin Limited (Lupin) announced the launch of the United States Food and Drug Administration (FDA) approved cyanocobalamin nasal spray, 500 mcg/spray (one spray per device),
Cyanocobalamin nasal spray, 500 mcg/spray (one spray per device) is a generic equivalent of Nascobal nasal spray, 500 mcg/spray of Par Pharmaceutical, Inc.
It is indicated for: Vitamin B12 maintenance therapy in adult patients with pernicious anaemia who are in remission following intramuscular vitamin B12 therapy and who have no nervous system involvement; Treatment of adult patients with dietary, drug-induced, or malabsorption related vitamin B12 deficiency not due to pernicious anaemia; Prevention of vitamin B12 deficiency in adult patients with vitamin B12 requirements more than normal.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!